Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Frequent hepatitis B virus rebound among HIV-hepatitis B virus-coinfected patients following antiretroviral therapy interruption

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Non-Hodgkin lymphoma risk in adults living with HIV across five continents

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Aging and the evolution of comorbidities among HIV-positive individuals in a European cohort

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. No evidence of increased risk of thyroid dysfunction in well-treated people living with HIV

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. No Neurocognitive Advantage for Immediate Antiretroviral Treatment in adults with greater than 500 CD4+ T Cell Counts

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Gregory J Dore
  • Vicente Soriano
  • Jürgen Rockstroh
  • Bernd Kupfer
  • Ellen Tedaldi
  • Lars Peters
  • Jacqueline Neuhaus
  • Massimo Puoti
  • Marina B Klein
  • Amanda Mocroft
  • Bonaventura Clotet
  • Jens D Lundgren
  • SMART INSIGHT study group
View graph of relations
The impact of antiretroviral therapy (ART) interruption in HIV-hepatitis B virus (HBV)-coinfected patients was examined in the Strategic Management of AntiRetroviral Therapy (SMART) study.
Original languageEnglish
JournalAIDS
Volume24
Issue number6
Pages (from-to)857-65
Number of pages9
ISSN0269-9370
DOIs
Publication statusPublished - 2010

    Research areas

  • Adult, Antiretroviral Therapy, Highly Active, CD4 Lymphocyte Count, DNA, Viral, Drug Resistance, Viral, Drug-Induced Liver Injury, Female, HIV Infections, HIV-1, Hepatitis B virus, Hepatitis B, Chronic, Humans, Male, Middle Aged

ID: 34777049